Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors

NCT04096638 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma
Head and Neck Squamous Cell Carcinoma
Solid Tumor

Interventions

DRUG: SB 11285
DRUG: Atezolizumab

Sponsor

invoX Pharma Limited